home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

The Connectivity Map Of Multi-Drug Combinations

  March, 8 2007 10:28
your information resource in human molecular genetics
The response to drug combinations critically depends on how their biological targets are connected, according to a study published online in Molecular Systems Biology. Understanding how multi-drug combinations work is vital in medicine, in order to rationalize their use and discover novel targets.

Joseph Lehár and colleagues analyzed the response of yeast and human tumour cell lines to thousands of drug pairs, and compared these experimental data to a computational model. By systematically measuring the biological effects of drug pairs over a range of concentrations, 'response surfaces' could be constructed. This strategy enabled the authors to establish a clear relationship between the shape of the biological 'response surface' and the type of connection linking the targeted biochemical pathways.

This study provides a general framework to analyze the effects of drug combinations and will help future researchers to better understand and develop effective multi-drug therapeutics.

Author contact:

Joseph Lehár (CombinatoRx Incorporated, Cambridge, MA, USA)
E-mail: jlehar@combinatorx.com

Editorial contact:

Thomas Lemberger (Molecular Systems Biology, Germany)
E-mail: msb@embo.org

Abstract available online.

(C) Molecular Systems Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.